BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21958464)

  • 1. Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity.
    Kerick M; Isau M; Timmermann B; Sültmann H; Herwig R; Krobitsch S; Schaefer G; Verdorfer I; Bartsch G; Klocker H; Lehrach H; Schweiger MR
    BMC Med Genomics; 2011 Sep; 4():68. PubMed ID: 21958464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STmut: a framework for visualizing somatic alterations in spatial transcriptomics data of cancer.
    Chen L; Chang D; Tandukar B; Deivendran D; Pozniak J; Cruz-Pacheco N; Cho RJ; Cheng J; Yeh I; Marine C; Bastian BC; Ji AL; Shain AH
    Genome Biol; 2023 Nov; 24(1):273. PubMed ID: 38037084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues.
    Mendez P; Fang LT; Jablons DM; Kim IJ
    Sci Rep; 2017 Jun; 7(1):4055. PubMed ID: 28642587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.
    Dunn TA; Fedor HL; De Marzo AM; Luo J
    Asian J Androl; 2012 May; 14(3):385-92. PubMed ID: 22306912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the Hi-C Technology for Molecular Genetic Analysis of Formalin-Fixed Paraffin-Embedded Sections of Tumor Tissues.
    Gridina MM; Stepanchuk YK; Nurridinov MA; Lagunov TA; Torgunakov NY; Shadsky AA; Ryabova AI; Vasiliev NV; Vtorushin SV; Gerashchenko TS; Denisov EV; Travin MA; Korolev MA; Fishman VS
    Biochemistry (Mosc); 2024 Apr; 89(4):637-652. PubMed ID: 38831501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mate pair sequencing of whole-genome-amplified DNA following laser capture microdissection of prostate cancer.
    Murphy SJ; Cheville JC; Zarei S; Johnson SH; Sikkink RA; Kosari F; Feldman AL; Eckloff BW; Karnes RJ; Vasmatzis G
    DNA Res; 2012 Oct; 19(5):395-406. PubMed ID: 22991452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGS method for parallel processing of high quality, damaged or fragmented input material using target enrichment.
    Lyander A; Gellerbring A; Hägglund M; Elhami K; Wirta V
    PLoS One; 2024; 19(5):e0304411. PubMed ID: 38809937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massively parallel sequencing: the new frontier of hematologic genomics.
    Johnsen JM; Nickerson DA; Reiner AP
    Blood; 2013 Nov; 122(19):3268-75. PubMed ID: 24021669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved understanding of cancer genomics through massively parallel sequencing.
    Teer JK
    Transl Cancer Res; 2014 Jun; 3(3):243-259. PubMed ID: 26146607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.
    Hedegaard J; Thorsen K; Lund MK; Hein AM; Hamilton-Dutoit SJ; Vang S; Nordentoft I; Birkenkamp-Demtröder K; Kruhøffer M; Hager H; Knudsen B; Andersen CL; Sørensen KD; Pedersen JS; Ørntoft TF; Dyrskjøt L
    PLoS One; 2014; 9(5):e98187. PubMed ID: 24878701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.
    Spencer DH; Sehn JK; Abel HJ; Watson MA; Pfeifer JD; Duncavage EJ
    J Mol Diagn; 2013 Sep; 15(5):623-33. PubMed ID: 23810758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens.
    Hadd AG; Houghton J; Choudhary A; Sah S; Chen L; Marko AC; Sanford T; Buddavarapu K; Krosting J; Garmire L; Wylie D; Shinde R; Beaudenon S; Alexander EK; Mambo E; Adai AT; Latham GJ
    J Mol Diagn; 2013 Mar; 15(2):234-47. PubMed ID: 23321017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens.
    Yost SE; Smith EN; Schwab RB; Bao L; Jung H; Wang X; Voest E; Pierce JP; Messer K; Parker BA; Harismendy O; Frazer KA
    Nucleic Acids Res; 2012 Aug; 40(14):e107. PubMed ID: 22492626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
    Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
    Wagle N; Berger MF; Davis MJ; Blumenstiel B; Defelice M; Pochanard P; Ducar M; Van Hummelen P; Macconaill LE; Hahn WC; Meyerson M; Gabriel SB; Garraway LA
    Cancer Discov; 2012 Jan; 2(1):82-93. PubMed ID: 22585170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
    Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
    PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchored multiplex PCR for targeted next-generation sequencing.
    Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
    Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
    Frampton GM; Fichtenholtz A; Otto GA; Wang K; Downing SR; He J; Schnall-Levin M; White J; Sanford EM; An P; Sun J; Juhn F; Brennan K; Iwanik K; Maillet A; Buell J; White E; Zhao M; Balasubramanian S; Terzic S; Richards T; Banning V; Garcia L; Mahoney K; Zwirko Z; Donahue A; Beltran H; Mosquera JM; Rubin MA; Dogan S; Hedvat CV; Berger MF; Pusztai L; Lechner M; Boshoff C; Jarosz M; Vietz C; Parker A; Miller VA; Ross JS; Curran J; Cronin MT; Stephens PJ; Lipson D; Yelensky R
    Nat Biotechnol; 2013 Nov; 31(11):1023-31. PubMed ID: 24142049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.
    Oh E; Choi YL; Kwon MJ; Kim RN; Kim YJ; Song JY; Jung KS; Shin YK
    PLoS One; 2015; 10(12):e0144162. PubMed ID: 26641479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.